C
Centro de Investigacion Clinica del Sur | Temuco, Chile
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Apixaban
Milvexian
Talazoparib
Enzalutamide
GLPG0634
Tocilizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...
Enrolling
Acute Coronary Syndrome
Drug: Milvexian
Other: Placebo
The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...
Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian
This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of tal...
Active, not recruiting
mCRPC
Drug: Talazoparib with enzalutamide
Drug: Placebo with enzalutamide
Trial sponsors
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems